<- Go Home
NeoPharm CO., LTD.
NeoPharm CO., LTD. engages in the manufacturing and sale of skin care products in South Korea. The company provides Atopalm, a non-steroid product for sensitive and dry skin; skin dermo-cosmetic products under the Real Barrier brand name; sensitive, dry, oily, or trouble-prone skin care products under the ZEROID brand; body moisturizers under the Derma-B brand name; sport care products under the MISSION ATHELETCARE brand; and dermArtlogy, a 1:1 consulting cosmetic brand. NeoPharm CO., LTD. was founded in 2000 and is headquartered in Daejeon, South Korea.
Market Cap
KRW 210.2B
Volume
113.4K
Cash and Equivalents
KRW 18.2B
EBITDA
KRW 27.8B
Tax Rate Collected
N/A
Tax Rate Ratio
N/A
Gross Profit
KRW 74.0B
Profit Margin
62.20%
52 Week High
KRW 17.1K
52 Week Low
KRW 10.1K
Dividend
N/A
Price / Book Value
1.19
Price / Earnings
9.11
Price / Tangible Book Value
1.20
Enterprise Value
KRW 84.3B
Enterprise Value / EBITDA
3.03
Operating Income
KRW 24.7B
Return on Equity
13.69%
Return on Assets
8.33
Cash and Short Term Investments
KRW 126.5B
Debt
KRW 629.4M
Equity
KRW 176.9B
Revenue
KRW 119.0B
Unlevered FCF
KRW 9.8B
Sector
Personal Care Products
Category
N/A
Hedge Funds that own this stock
PREMIUM
Upgrade to Yellowbrick Premium to unlock the Professional Funds that own this company (and many other perks).
Upgrade to Yellowbrick PremiumYellowbrick Portfolios that own this stock
PREMIUM
Upgrade to Yellowbrick Premium to unlock the Yellowbrick portfolios that own this company (and many other perks).
Upgrade to Yellowbrick Premium